Lupin gains FDA nod for generic Diflucan Tablets production
Lupin Limited, a recognized global pharmaceutical powerhouse, proudly announced its receipt of the much-anticipated approval from the US Food and Drug Administration (FDA). This authorization paves the way for its Abbreviated New Drug Application concerning Fluconazole Tablets USP in varying strengths: 50 mg, 100 mg, 150 mg, and 200 mg. These tablets are designed to […]